Rafael Rosengarten joins the Midstage Startup Momentum Podcast with Roland Siebelink
"Build a Great Company and a Great Business Follows" [...]
Genialis Presents Poster on KRAS Expression Signature Validation in Lung Cancer
First research poster by Genialis on KRAS/MAPK therapeutic area [...]
People first: building a company that inspires impactful work with Genialis leadership team | Podcast #30
Welcome to Talking Precision Medicine — the podcast in [...]
Genialis and OncXerna publish a novel RNA-seq and machine learning based biomarker in Frontiers in Oncology
The XernaTM TME Panel classifies patients based on tumor microenvironment [...]
Genialis Unveils Expressions Version 3.0, Cloud Software for Faster, More Secure Data Processing and Management
Updated Microservices and Front End Architectures Deliver Vastly Improved [...]
The Xerna™ TME Panel potentially predicts response to a combination of the TLR9 agonist vidutolimod and PD-1 inhibitor pembrolizumab in metastatic melanomas with prior anti-PD-1 treatment
Co-presented by Genialis’ Daniel Pointing at AACR Annual Meeting 2023, this [...]
ResponderID™: The Biology-First Machine Learning Platform for Biomarker Discovery
Rarely has a complex gene signature been successfully translated [...]
Genialis Raises $13M to Build Clinical Biomarkers that Predict Patient Response
Through AI/ML-enabled platform with a biology-first approach, Genialis looks [...]
Communication, the key to building community with Susanna Harris | Podcast #29
Welcome to Talking Precision Medicine — the podcast in [...]
Pitfalls and Rewards of Setting Up a Liquid Biopsy Approach for the Detection of Driver Mutations in Circulating Tumor DNAs: Our Institutional Experience
Genialis has been supporting the California Pacific Medical Center, Research [...]
